Vascular Health and Risk Management

Official journal of the International Society of Vascular Health (ISVH)Indexed:EmBase, Scopus and the Elsevier Bibliographic databasesAmerican Chemical Society's Chemical Abstracts Service (CAS)MedLinePubMedISSN 1176-6344 (Print)ISSN 1178-2048 (Online)An international, peer-reviewed journal of therapeutics and risk management, focusing on concise rapid reporting of clinical studies on the processes involved in the maintenance of vascular health; the monitoring, prevention, and treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes. In addition, the journal will also seek to define drug usage in terms of ultimate uptake and acceptance by the patient and healthcare professional.Key BenefitsConcise rapid reportingClinical therapeutics and pharmacology focusCardiovascular and metabolic disordersAims and scopeSubject areas include:Endothelial function, inflammation, biochemical and cellular processes, markers, coagulation disorders, and thromboembolism Lipid metabolism and dyslipidemia Metabolic disorders, such as diabetes, and their impact on vascular health Stroke, heart failure, atherosclerosis, coronary artery disease, hypertension, peripheral vascular disease, pulmonary embolism, and diabetic involvement in nephropathy and retinopathy Screening and prevention studies Risk factor analyses Clinical studies of compounds used in the management of cardiovascular and metabolic disorders (clinical trials, pharmacodynamic, kinetic reports), including individual compounds, combinations, and new formulations Studies in specific populations, particularly the elderly and at-risk populations Safety and postmarketing surveillance studies, outcome studies, and economic analyses of drug treatment and disease, including modeling Drug management of specific diseases, clinical guidelines, formulary management Risk management programs, patient and health education programs and studies. These areas are addressed through:Original research (full papers and concise rapid reports)Reviews Systematic reviews of individual new or important drugs where a change in therapeutic management of a disease may be indicatedExpert opinion and commentary.